Cargando…
MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental Mesothelioma
SIMPLE SUMMARY: The role of MTH1 in the tumor-related immune responses in mesothelioma remains unknown. We hypothesized that MTH1 regulates immune responses and enhances the efficacy of anti-PD-L1 immunotherapy. We focused on central immune players such as tumor-associated macrophages. MTH1 inhibiti...
Autores principales: | Magkouta, Sophia F., Vaitsi, Photene C., Iliopoulou, Marianthi P., Pappas, Apostolos G., Kosti, Chrysavgi N., Psarra, Katherina, Kalomenidis, Ioannis T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605650/ https://www.ncbi.nlm.nih.gov/pubmed/37894329 http://dx.doi.org/10.3390/cancers15204962 |
Ejemplares similares
-
CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy
por: Magkouta, Sophia Fotiou, et al.
Publicado: (2021) -
CSF1/CSF1R signaling mediates malignant pleural effusion formation
por: Kosti, Chrysavgi N., et al.
Publicado: (2022) -
Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion
por: Magkouta, Sophia, et al.
Publicado: (2016) -
Targeting Tie-2/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implications
por: Magkouta, Sophia, et al.
Publicado: (2018) -
Kinetics of Immune Subsets in COVID-19 Patients Treated with Corticosteroids
por: Pappas, Apostolos Georgios, et al.
Publicado: (2022)